Baxter International - BAX Stock Forecast, Price & News

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
View BAX analyst ratings or view top-rated stocks.

13 equities research analysts have issued 12-month price objectives for Baxter International's shares. Their BAX share price forecasts range from $51.00 to $91.00. On average, they anticipate the company's stock price to reach $62.93 in the next twelve months. This suggests a possible upside of 36.0% from the stock's current price.
View analysts price targets for BAX or view top-rated stocks among Wall Street analysts.

Baxter International's stock was trading at $50.97 at the beginning of 2023. Since then, BAX stock has decreased by 9.2% and is now trading at $46.28.
View the best growth stocks for 2023 here.

Baxter International saw a increase in short interest in December. As of December 30th, there was short interest totaling 7,410,000 shares, an increase of 30.7% from the December 15th total of 5,670,000 shares. Based on an average daily volume of 4,850,000 shares, the short-interest ratio is currently 1.5 days.
View Baxter International's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our BAX earnings forecast.

Baxter International will be holding an earnings conference call on Thursday, February 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Baxter International Inc. (NYSE:BAX) announced its quarterly earnings results on Wednesday, October, 27th. The medical instruments supplier reported $1.02 EPS for the quarter, topping analysts' consensus estimates of $0.94 by $0.08. The medical instruments supplier had revenue of $3.23 billion for the quarter, compared to analysts' expectations of $3.23 billion. Baxter International had a negative net margin of 16.12% and a positive trailing twelve-month return on equity of 22.65%. Baxter International's revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.83 earnings per share.
Read the conference call transcript.

Baxter International announced a quarterly dividend on Tuesday, November 15th. Stockholders of record on Friday, December 2nd will be given a dividend of $0.29 per share on Tuesday, January 3rd. This represents a $1.16 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Thursday, December 1st.
Read our dividend analysis for BAX.

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 2.57%.
Read our dividend analysis for BAX.

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International's stock is owned by many different institutional and retail investors. Top institutional shareholders include Coho Partners Ltd. (0.39%), New York State Common Retirement Fund (0.30%), Sumitomo Mitsui Trust Holdings Inc. (0.28%), River Road Asset Management LLC (0.14%), New York State Teachers Retirement System (0.10%) and Bartlett & Co. LLC (0.06%). Insiders that own company stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth and Sean Martin.
View institutional ownership trends.

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BAX stock can currently be purchased for approximately $46.28.

Baxter International (NYSE:BAX) has a market capitalization of $23.33 billion and generates $12.78 billion in revenue each year. The medical instruments supplier earns $1.28 billion in net income (profit) each year or ($4.72) on an earnings per share basis.

The company employs 60,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.